NCT04426214 is a NA clinical trial of tDCS in Stimulant Use, sponsored by University of Minnesota.

Who is sponsoring NCT04426214?

NCT04426214 is sponsored by University of Minnesota.

What drugs are being tested in NCT04426214?

Interventions in NCT04426214: tDCS, Cognitive Training.

What condition does NCT04426214 study?

NCT04426214 studies Stimulant Use, Alcohol Use Disorder.

Is NCT04426214 still recruiting?

NCT04426214 is currently recruiting now. Last updated 26 August 2025.

Last reviewed 2025-08-26 · How we verify

NCT04426214

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuromodulation and Cognitive Training for Substance Use Disorders

Recruiting now NA Last updated 26 August 2025

What this trial tests

NA trial testing tDCS in Stimulant Use in 80 participants. Currently enrolling.

Timeline

16 July 2021

Primary endpoint
1 September 2026

1 September 2026

Quick facts

Lead sponsor	University of Minnesota
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	80
Start date	16 July 2021
Primary completion	1 September 2026
Estimated completion	1 September 2026
Sites	1 location across United States

Drugs / interventions tested

tDCS — full drug profile →
Cognitive Training

Conditions studied

Stimulant Use — all drugs for Stimulant Use →
Alcohol Use Disorder — all drugs for Alcohol Use Disorder →

Sponsor

University of Minnesota

Who can join

Adults 18 to 65, any sex, with Stimulant Use or Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The relapsing nature of substance use disorder is a major obstacle to successful treatment. About 70% of those entering treatment will relapse within one year. To improve treatment outcome, new interventions targeting the underlying brain biomarkers of relapse vulnerability hold significant promise in reducing this critical public health problem. This study is testing a new intervention, namely tDCS-Augmented Cognitive Training, to engage these brain biomarkers to improve cognition and improve treatment outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of tDCS

Trials testing the same drug.

NCT07400939 — Brain Stimulation Combined With Watching Hand Movements to Improve Hand Recovery in Chronic Stroke · NA · recruiting
NCT06994390 — Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial) · NA · not yet recruiting
NCT07358832 — Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease · NA · recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT06972368 — Home-Based tDCS for Depression in BPD · NA · recruiting

Other recruiting trials for Stimulant Use

Currently open trials in the same condition.

NCT06814275 — Project neuroARTEMIS · NA · recruiting
NCT05835921 — Enhancing Prospective Thinking in Early Recovery · NA · recruiting
NCT04899024 — PrEP Affect Regulation Treatment Innovation · NA · active not recruiting
NCT03935646 — Acute Effects of Stimulant Medication in College Students With ADHD · Phase 2 · recruiting
NCT03470480 — rTMS for Craving in Methamphetamine Use Disorder · NA · recruiting

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04426214 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 26 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04426214.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing